Silexion Therapeutics Corp - SLXN
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | History | Added to | 20,926 | 26 | 0.0% | 0.0% | 1 | +8,721 | 71.45% | Q1 2026 | May 15, 2026 |
| TWO SIGMA SECURITIES, LLC | History | New | 11,657 | 14 | 0.0% | — | 2 | +11,657 | New | Q1 2026 | May 15, 2026 |
| MONTAG A & ASSOCIATES INC | History | No change | 3,000 | 3 | 0.0% | 0.0% | 3 | 0 | 0.0% | Q1 2026 | Apr 29, 2026 |
| UBS Group AG | History | Reduced | 517 | 0 | — | 0.0% | — | -1,174 | -69.43% | Q1 2026 | May 05, 2026 |
| SBI Securities Co., Ltd. | History | Reduced | 20 | 0 | — | 0.0% | — | -1,040 | -98.11% | Q1 2026 | Apr 27, 2026 |
| JONES FINANCIAL COMPANIES LLLP | History | No change | 26 | 0 | — | — | — | 0 | 0.0% | Q1 2026 | May 15, 2026 |
| Pflug Koory, LLC | History | No change | 333 | 0 | — | — | — | 0 | 0.0% | Q1 2026 | Apr 21, 2026 |